Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03981796
Title A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

endometrial cancer

Therapies

Carboplatin + Paclitaxel

Carboplatin + Dostarlimab-gxly + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | BEL


No variant requirements are available.